IDEXX Labs Fetches Double-Digit Profit Growth
IDEXX Laboratories (NASDAQ: IDXX), a diversified pet healthcare company, reported its second-quarter results on Thursday.
Revenue growth held steady at 7%, although the number would have been a little bit higher had it not been for currency movements. Steady margin improvements allowed the company to report 16% growth in EPS, and management boosted guidance in response to the broad-based strength.
Metric
Quelle Fool.com
